Sarepta Therapeutics
SRPT
SRPT
426 hedge funds and large institutions have $5.49B invested in Sarepta Therapeutics in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 143 increasing their positions, 149 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 101
49% less capital invested
Capital invested by funds: $10.7B → $5.49B (-$5.19B)
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Holders
426
Holding in Top 10
5
Calls
$102M
Puts
$81.3M
Top Buyers
| 1 | +$62.6M | |
| 2 | +$57.4M | |
| 3 | +$37M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$36.9M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$33.3M |
Top Sellers
| 1 | -$117M | |
| 2 | -$86.4M | |
| 3 | -$82M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$67.8M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$46.1M |
